Proficio Capital Partners LLC Makes New Investment in Henry Schein, Inc. (NASDAQ:HSIC)

Proficio Capital Partners LLC bought a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 13,632 shares of the company's stock, valued at approximately $943,000.

A number of other large investors have also recently bought and sold shares of HSIC. Smartleaf Asset Management LLC increased its position in shares of Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after purchasing an additional 143 shares in the last quarter. CIBC Asset Management Inc increased its stake in shares of Henry Schein by 1.0% in the fourth quarter. CIBC Asset Management Inc now owns 17,849 shares of the company's stock valued at $1,235,000 after buying an additional 169 shares in the last quarter. Studio Investment Management LLC raised its holdings in shares of Henry Schein by 3.8% in the third quarter. Studio Investment Management LLC now owns 4,674 shares of the company's stock valued at $341,000 after buying an additional 172 shares during the last quarter. Metis Global Partners LLC grew its holdings in Henry Schein by 4.7% during the 4th quarter. Metis Global Partners LLC now owns 4,203 shares of the company's stock worth $291,000 after acquiring an additional 187 shares during the last quarter. Finally, Central Pacific Bank Trust Division increased its position in Henry Schein by 2.0% in the 4th quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company's stock valued at $706,000 after acquiring an additional 200 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors.

Remove Ads

Insider Buying and Selling at Henry Schein

In other news, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now directly owns 24,805 shares of the company's stock, valued at $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company's stock.

Wall Street Analysts Forecast Growth

HSIC has been the subject of a number of research reports. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and raised their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Mizuho started coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price target for the company. Barrington Research reaffirmed an "outperform" rating and issued a $90.00 price objective on shares of Henry Schein in a research note on Wednesday, February 26th. UBS Group lowered their target price on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Finally, Wells Fargo & Company initiated coverage on Henry Schein in a research report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price target on the stock. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $81.10.

Henry Schein Stock Down 2.0 %

NASDAQ HSIC traded down $1.38 during trading on Tuesday, hitting $69.38. The stock had a trading volume of 1,295,927 shares, compared to its average volume of 1,508,724. The company has a market capitalization of $8.62 billion, a PE ratio of 28.55, a P/E/G ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.49. The company's 50-day moving average price is $74.82 and its two-hundred day moving average price is $72.64. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The business had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business's revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.66 EPS. As a group, sell-side analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.